Source of drug resistant Plasmodium falciparum in a potential malaria elimination site in Saudi Arabia

Infection, Genetics and Evolution

Volumn 12, Issue 6, 2012, Pages 1253-1259

  Al Farsi, Hissa M ^a   Al Hashami, Zainab S ^a   Bin Dajem, Saad M ^b   Al Sheikh, Adel Ali H ^c   Al Qahtani, Ahmed ^d,e   Beja Pereira, Albano ^f   Idris, Mohamed A ^a   Babiker, Hamza A ^a,g  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b KING KHALID UNIVERSITY   (Saudi Arabia)

^c MOH   (Saudi Arabia)

^d KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^e KING SAUD UNIVERSITY   (Saudi Arabia)

^f CENTRO DE INVESTIGAÇÃO EM BIODIVERSIDADE E RECURSOS GENÉTICOS   (Portugal)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Evolutionary origin; Plasmodium falciparum; Pyrimethamine sulfadoxine resistance; Saudi Arabia

Indexed keywords

ARTESUNATE; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; PYRIMETHAMINE PLUS SULFADOXINE;

ALLELE; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CONTROLLED STUDY; DHFR GENE; DHPS GENE; DNA FLANKING REGION; DNA POLYMORPHISM; GENE; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; HAPLOTYPE; HETEROZYGOTE; HUMAN; MALARIA CONTROL; MALARIA FALCIPARUM; MICROSATELLITE MARKER; NONHUMAN; PARASITE IDENTIFICATION; PARASITE ISOLATION; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; POPULATION MIGRATION; PRIORITY JOURNAL; SAUDI ARABIA; SUDAN; WILD TYPE;

ANTIMALARIALS; DIHYDROPTEROATE SYNTHASE; DNA, PROTOZOAN; DRUG COMBINATIONS; DRUG RESISTANCE; HAPLOTYPES; HUMANS; MALARIA, FALCIPARUM; MICROSATELLITE REPEATS; MODELS, GENETIC; MUTATION; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; SAUDI ARABIA; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE;

ARTESUNATE; PLASMODIUM FALCIPARUM;

EID: 84861926547     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2012.03.011     Document Type: Article

References (37)

1. Abdel-Hameed, A.A., 2003. Antimalarial drug resistance in the Eastern Mediterranean Region. Eastern Mediterranean Health Journal = La Revue De Santé De La Méditerranée Orientale = Al-Majallah Al-S{dot below}ih{dot below}h{dot below}iyah Li-Sharq Al-Mutawassit{dot below} 9, 492-508.
2. Abdel-Muhsin A.A., Mackinnon M.J., Awadalla P., Ali E., Suleiman S., Ahmed S., Walliker D., Babiker H.A. Local differentiation in Plasmodium falciparum drug resistance genes in Sudan. Parasitology 2003, 126:391-400.
3. Akala H.M., Eyase F.L., Cheruiyot A.C., Omondi A.A., Ogutu B.R., Waters N.C., Johnson J.D., Polhemus M.E., Schnabel D.C., Walsh D.S. Antimalarial drug sensitivity profile of Western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay and molecular analysis. Am. J. Trop. Med. Hyg. 2011, 85:34-41.
4. Alano P., Read D., Bruce M., Aikawa M., Kaido T., Tegoshi T., Bhatti S., Smith D.K., Luo C., Hansra S., Carter R., Elliott J.F. COS cell expression cloning of Pfg377, a Plasmodium falciparum gametocyte antigen associated with osmiophilic bodies. Mol. Biochem. Parasitol. 1995, 74:143-156.
5. Al-Harthi S.A. Detection of drug resistance markers for chloroquine and pyrimethamine-sulfadoxine in Jazan Area, Saudi Arabia using PCR and restriction digestion. J. Egyp. Soc. Parasitol. 2007, 37:17-30.
6. Al-Harthi S.A., Jamjoom M.B. PCR assay in malaria diagnosis using filter paper samples from Jazan Region, Saudi Arabia. J. Egyp. Soc. Parasitol. 2008, 38:693-706.
7. Al-Saai S., Kheir A., Abdel-Muhsin A.-M.A., Al-Ghazali A., Nwakanma D., Swedberg G., Babiker H.A. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan. Infect. Genet. Evol. 2009, 9:778-783.
8. Koita O.A., Doumbo O.K., Ouattara A., Tall L.K., Konaré A., Diakité M., Diallo M., Sagara I., Masinde G.L., Doumbo S.N., Dolo A., Tounkara A., Traoré I., Krogstad D.J. False-negative rapid diagnostic tests for malaria and deletion of the histidine-rich repeat region of the hrp2 gene. Am .J. Trop. Med. Hyg. 2012, 86:194-198.
9. Ariey F., Duchemin J.-B., Robert V. Metapopulation concepts applied to falciparum malaria and their impacts on the emergence and spread of chloroquine resistance. Infect. Genet. Evol. 2003, 2:185-192.
10. Babiker H.A., Abdel-Muhsin A.B.A., Ranford-Cartwright L.C., Satti G., Walliker D. Characteristics of Plasmodium falciparum parasites that survive the lengthy dry season in eastern Sudan where malaria transmission is markedly seasonal. Am. J. Trop. Med. Hyg. 1998, 59:582-590.
11. Babiker H.A., Satti G., Ferguson H., Bayoumi R., Walliker D. Drug resistant Plasmodium falciparum in an area of seasonal transmission. Acta Trop. 2005, 94:260-268.
12. Bandelt H.J., Forster P., Röhl A. Median-joining networks for inferring intraspecific phylogenies. Mol. Biol. Evol. 1999, 16:37-48.
13. Bin Dajem S.M., Al-Qahtani A. Analysis of gene mutations involved in chloroquine resistance in Plasmodium falciparum parasites isolated from patients in the southwest of Saudi Arabia. Ann. Saudi Med. 2010, 30:187-192.
14. Bin Dajem S.M., Al-Farsi H.M., Al-Hashami Z.S., Al-Sheikh A.A., Al-Qahtani A., Babiker H.A. Distribution of drug resistance genotypes in Plasmodium falciparum in an area of limited parasite diversity in saudi arabia. Am. J. Trop. Med. Hyg. 2012, 86:782-788.
15. Bruce M.C., Donnelly C.A., Alpers M.P., Galinski M.R., Barnwell J.W., Walliker D., Day K.P. Cross-species interactions between malaria parasites in humans: 1. Science 2000, 287:845-848.
16. Certain L.K., Briceno M1., Kiara S.M., Nzila A.M., Watkins W.M., Sibley C.H. Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance Kilifi, Kenya, 1987-2006. J. Infect. Dis. 2008, 197:1743-2175.
17. Costanzo M.S., Brown K.M., Hartl D.L. Fitness trade-offs in the evolution of dihydrofolate reductase and drug resistance in Plasmodium falciparum. PLoS ONE 2011, 6(5):e19636.
18. Ghanchi N.K., Ursing J., Beg M.A., Veiga M.I., Jafri S., Mårtensson A. Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan. Malar. J. 2011, 10:18.
19. Jalousian F., Dalimi A., Samiee S.M., Ghaffarifar F., Soleymanloo F., Naghizadeh R. Mutation in pfmdr1 gene in chloroquine-resistant Plasmodium falciparum isolates, Southeast Iran. Int. J. Infect. Dis. 2008, 12:630-634.
20. Kawai A., Arita N., Matsumoto Y., Kawabata M., Chowdhury M.S., Saito-Ito A. Efficacy of chloroquine plus primaquine treatment and pfcrt mutation in uncomplicated falciparum malaria patients in Rangamati, Bangladesh. Parasitol. Int. 2011, 60:341.
21. Lynch C., Pearce R., Pota H., Cox J., Abeku T.A., Rwakimari J., Naidoo I., Tibenderana J., Roper C. Emergence of a dhfr mutation conferring high-level drug resistance in Plasmodium falciparum populations from southwest Uganda. J. Infect. Dis. 2008, 197:1598. U1566.
22. McCollum A.M., Poe A.C., Hamel M., Huber C., Zhou Z., Shi Y.P., Ouma P., Vulule J., Bloland P., Slutsker L., Barnwell J.W., Udhayakumar V., Escalante A.A. Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. J. Infect. Dis. 2006, 194:189-197.
23. McCollum A.M., Basco L.K., Tahar R., Udhayakumar V., Escalante A.A. Hitchhiking and selective sweeps of Plasmodium falciparum sulfadoxine and pyrimethamine resistance alleles in a population from Central Africa. Antimicrob. Agents Chemother. 2008, 52:4089-4097.
24. Menegon M., Severini C., Sannella A., Paglia M.G., Sangaré D., Abdel-Wahab A., Abdel-Muhsin A.A., Babiker H., Walliker D., Alano P. Genotyping of Plasmodium falciparum gametocytes by reverse transcriptase polymerase chain reaction. Mol. Biochem. Parasitol. 2000, 111:153-161.
25. Mita T., Tanabe K., Takahashi N., Culleton R., Ndounga M., Dzodzomenyo M., Akhwale W.S., Kaneko A., Kobayakawa T. Indigenous evolution of Plasmodium falciparum pyrimethamine resistance multiple times in Africa. J. Antimicrob. Chemother. 2009, 63:252-255.
26. MOH-Oman, 2009. Annual Health Report Sultanate Of Oman, p. 63.
27. Naidoo I., Roper C. Following the path of most resistance. dhps K540E dispersal in African Plasmodium falciparum. Trends Parasitol. 2010, 26:447-456.
28. Nair S., Williams J.T., Brockman A., Paiphun L., Mayxay M., Newton P.N., Guthmann J.-P., Smithuis F.M., Hien T.T., White N.J., Nosten F., Anderson T.J.C. A selective sweep driven by pyrimethamine treatment in southeast Asian malaria parasites. Mol. Biol. Evol. 2003, 20:1526-1536.
29. Park S.D.E. Trypanotolerance in West African Cattle and the Population Genetic Effects of Selection 2001, University of Dublin.
30. Plowe C.V., Djimde A., Bouare M., Doumbo O., Wellems T.E. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am. J. Trop. Med. Hyg. 1995, 52:565-568.
31. Plowe C.V., Cortese J.F., Djimde A., Nwanyanwu O.C., Watkins W.M., Winstanley P.A., Estrada-Franco J.G., Mollinedo R.E., Avila J.C., Cespedes J.L., Carter D., Doumbo O.K. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J. Infect. Dis. 1997, 176:1590-1596.
32. Raymond M., Rousset F. GENEPOP (version 1.2): Population genetics software for exact tests and ecumenism. J. Hered. 1995, 86:248.
33. Roper C., Pearce R., Nair S., Sharp B., Nosten F., Anderson T. Intercontinental spread of pyrimethamine-resistant malaria. Science 2004, 305:1124.
34. Shah N.K., Dhillon G.P.S., Dash A.P., Arora U., Meshnick S.R., Valecha N. Antimalarial drug resistance of Plasmodium falciparum in India: changes over time and space. Lancet Infect. Dis. 2011, 11:57-64.
35. Sultan D.M., Khalil M.M., Abdouh A.S., Doleh W.F., Al Muthanna A.A.M. Imported malaria in United Arab Emirates: evaluation of a new DNA extraction technique using nested PCR. Korean J. Parasitol. 2009, 47:227-233.
36. Weir B.S., Cockerham C. Estimating F-statistics for the analysis of population structure. Evolution 1984, 38:1358-1370.
37. WHO-EMRO, 2007. Malaria control and elimination in the Eastern Mediterranean 2006-2010.